nodes	percent_of_prediction	percent_of_DWPC	metapath
Vitamin E—GSTP1—schizophrenia	0.529	1	CbGaD
Vitamin E—PRKCA—cerebellar cortex—schizophrenia	0.00833	0.0483	CbGeAlD
Vitamin E—PRKCA—telencephalic ventricle—schizophrenia	0.00485	0.0281	CbGeAlD
Vitamin E—GSTA2—urine—schizophrenia	0.00424	0.0246	CbGeAlD
Vitamin E—HMOX1—blood plasma—schizophrenia	0.00361	0.0209	CbGeAlD
Vitamin E—TTPA—blood—schizophrenia	0.0032	0.0186	CbGeAlD
Vitamin E—PRKCB—telencephalon—schizophrenia	0.00302	0.0175	CbGeAlD
Vitamin E—TTPA—endocrine gland—schizophrenia	0.00278	0.0161	CbGeAlD
Vitamin E—SEC14L4—blood—schizophrenia	0.00278	0.0161	CbGeAlD
Vitamin E—GSTP1—urine—schizophrenia	0.00272	0.0158	CbGeAlD
Vitamin E—PPP2CA—forebrain—schizophrenia	0.00268	0.0155	CbGeAlD
Vitamin E—DGKA—telencephalon—schizophrenia	0.00249	0.0145	CbGeAlD
Vitamin E—PPP2CA—telencephalon—schizophrenia	0.00246	0.0143	CbGeAlD
Vitamin E—SEC14L4—endocrine gland—schizophrenia	0.00241	0.014	CbGeAlD
Vitamin E—PRKCA—blood plasma—schizophrenia	0.00231	0.0134	CbGeAlD
Vitamin E—PPP2CB—forebrain—schizophrenia	0.00228	0.0132	CbGeAlD
Vitamin E—GSTA2—blood plasma—schizophrenia	0.00221	0.0128	CbGeAlD
Vitamin E—PRKCB—blood—schizophrenia	0.0022	0.0127	CbGeAlD
Vitamin E—PRKCB—midbrain—schizophrenia	0.00217	0.0126	CbGeAlD
Vitamin E—PPP2CB—telencephalon—schizophrenia	0.00209	0.0121	CbGeAlD
Vitamin E—PPP2CA—gonad—schizophrenia	0.00205	0.0119	CbGeAlD
Vitamin E—TTPA—brain—schizophrenia	0.00199	0.0115	CbGeAlD
Vitamin E—HMOX1—forebrain—schizophrenia	0.00198	0.0115	CbGeAlD
Vitamin E—SEC14L2—endocrine gland—schizophrenia	0.0019	0.011	CbGeAlD
Vitamin E—HMOX1—telencephalon—schizophrenia	0.00182	0.0105	CbGeAlD
Vitamin E—DGKA—blood—schizophrenia	0.00181	0.0105	CbGeAlD
Vitamin E—PPP2CA—blood—schizophrenia	0.00179	0.0104	CbGeAlD
Vitamin E—SEC14L2—nervous system—schizophrenia	0.00178	0.0103	CbGeAlD
Vitamin E—PPP2CB—gonad—schizophrenia	0.00175	0.0101	CbGeAlD
Vitamin E—SEC14L2—central nervous system—schizophrenia	0.00172	0.00995	CbGeAlD
Vitamin E—GCLC—forebrain—schizophrenia	0.00171	0.00991	CbGeAlD
Vitamin E—SEC14L2—cerebellum—schizophrenia	0.00168	0.00972	CbGeAlD
Vitamin E—PRKCB—cerebellum—schizophrenia	0.00168	0.00972	CbGeAlD
Vitamin E—DGKA—endocrine gland—schizophrenia	0.00157	0.00912	CbGeAlD
Vitamin E—GCLC—telencephalon—schizophrenia	0.00157	0.00911	CbGeAlD
Vitamin E—PPP2CA—endocrine gland—schizophrenia	0.00155	0.009	CbGeAlD
Vitamin E—GSTM3—forebrain—schizophrenia	0.00153	0.00885	CbGeAlD
Vitamin E—PPP2CB—blood—schizophrenia	0.00152	0.00882	CbGeAlD
Vitamin E—HMOX1—gonad—schizophrenia	0.00152	0.00879	CbGeAlD
Vitamin E—PPP2CB—midbrain—schizophrenia	0.0015	0.00871	CbGeAlD
Vitamin E—DGKA—nervous system—schizophrenia	0.00147	0.00854	CbGeAlD
Vitamin E—PPP2CA—nervous system—schizophrenia	0.00145	0.00842	CbGeAlD
Vitamin E—NR1I2—endocrine gland—schizophrenia	0.00144	0.00837	CbGeAlD
Vitamin E—GSTP1—blood plasma—schizophrenia	0.00142	0.00824	CbGeAlD
Vitamin E—GSTO1—forebrain—schizophrenia	0.00142	0.00824	CbGeAlD
Vitamin E—DGKA—central nervous system—schizophrenia	0.00142	0.00822	CbGeAlD
Vitamin E—GSTM3—telencephalon—schizophrenia	0.0014	0.00814	CbGeAlD
Vitamin E—PPP2CA—central nervous system—schizophrenia	0.0014	0.00811	CbGeAlD
Vitamin E—DGKA—cerebellum—schizophrenia	0.00139	0.00804	CbGeAlD
Vitamin E—SEC14L2—brain—schizophrenia	0.00136	0.0079	CbGeAlD
Vitamin E—PRKCB—brain—schizophrenia	0.00136	0.0079	CbGeAlD
Vitamin E—HMOX1—blood—schizophrenia	0.00132	0.00766	CbGeAlD
Vitamin E—PPP2CB—endocrine gland—schizophrenia	0.00132	0.00765	CbGeAlD
Vitamin E—GCLC—gonad—schizophrenia	0.00131	0.00761	CbGeAlD
Vitamin E—GSTO1—telencephalon—schizophrenia	0.00131	0.00758	CbGeAlD
Vitamin E—PRKCA—forebrain—schizophrenia	0.00127	0.00734	CbGeAlD
Vitamin E—PPP2CB—nervous system—schizophrenia	0.00124	0.00716	CbGeAlD
Vitamin E—SOD1—telencephalon—schizophrenia	0.0012	0.00697	CbGeAlD
Vitamin E—PPP2CB—central nervous system—schizophrenia	0.00119	0.0069	CbGeAlD
Vitamin E—GSTM3—gonad—schizophrenia	0.00117	0.00679	CbGeAlD
Vitamin E—PRKCA—telencephalon—schizophrenia	0.00116	0.00675	CbGeAlD
Vitamin E—PPP2CB—cerebellum—schizophrenia	0.00116	0.00674	CbGeAlD
Vitamin E—HMOX1—endocrine gland—schizophrenia	0.00115	0.00665	CbGeAlD
Vitamin E—GCLC—midbrain—schizophrenia	0.00113	0.00655	CbGeAlD
Vitamin E—DGKA—brain—schizophrenia	0.00113	0.00653	CbGeAlD
Vitamin E—PPP2CA—brain—schizophrenia	0.00111	0.00644	CbGeAlD
Vitamin E—HMOX1—nervous system—schizophrenia	0.00107	0.00622	CbGeAlD
Vitamin E—HMOX1—central nervous system—schizophrenia	0.00103	0.00599	CbGeAlD
Vitamin E—GSTM3—blood—schizophrenia	0.00102	0.00592	CbGeAlD
Vitamin E—GSTM3—midbrain—schizophrenia	0.00101	0.00585	CbGeAlD
Vitamin E—GCLC—endocrine gland—schizophrenia	0.000992	0.00575	CbGeAlD
Vitamin E—PRKCA—gonad—schizophrenia	0.000972	0.00563	CbGeAlD
Vitamin E—GSTO1—blood—schizophrenia	0.00095	0.00551	CbGeAlD
Vitamin E—PPP2CB—brain—schizophrenia	0.000944	0.00547	CbGeAlD
Vitamin E—GSTO1—midbrain—schizophrenia	0.000939	0.00544	CbGeAlD
Vitamin E—GSTA2—gonad—schizophrenia	0.000931	0.0054	CbGeAlD
Vitamin E—GCLC—nervous system—schizophrenia	0.000928	0.00538	CbGeAlD
Vitamin E—GCLC—central nervous system—schizophrenia	0.000894	0.00518	CbGeAlD
Vitamin E—GSTM3—endocrine gland—schizophrenia	0.000886	0.00514	CbGeAlD
Vitamin E—SOD1—blood—schizophrenia	0.000874	0.00507	CbGeAlD
Vitamin E—GCLC—cerebellum—schizophrenia	0.000873	0.00506	CbGeAlD
Vitamin E—NQO1—forebrain—schizophrenia	0.000871	0.00505	CbGeAlD
Vitamin E—SOD1—midbrain—schizophrenia	0.000863	0.005	CbGeAlD
Vitamin E—PRKCA—blood—schizophrenia	0.000847	0.00491	CbGeAlD
Vitamin E—PRKCA—midbrain—schizophrenia	0.000836	0.00485	CbGeAlD
Vitamin E—GSTM3—nervous system—schizophrenia	0.000829	0.00481	CbGeAlD
Vitamin E—GSTO1—endocrine gland—schizophrenia	0.000824	0.00478	CbGeAlD
Vitamin E—HMOX1—brain—schizophrenia	0.00082	0.00476	CbGeAlD
Vitamin E—GSTA2—blood—schizophrenia	0.000811	0.0047	CbGeAlD
Vitamin E—NQO1—telencephalon—schizophrenia	0.000801	0.00465	CbGeAlD
Vitamin E—GSTM3—central nervous system—schizophrenia	0.000798	0.00463	CbGeAlD
Vitamin E—GSTM3—cerebellum—schizophrenia	0.00078	0.00452	CbGeAlD
Vitamin E—GSTP1—forebrain—schizophrenia	0.000779	0.00451	CbGeAlD
Vitamin E—GSTO1—nervous system—schizophrenia	0.000772	0.00447	CbGeAlD
Vitamin E—GSTO1—central nervous system—schizophrenia	0.000743	0.00431	CbGeAlD
Vitamin E—PRKCA—endocrine gland—schizophrenia	0.000734	0.00426	CbGeAlD
Vitamin E—GSTO1—cerebellum—schizophrenia	0.000726	0.00421	CbGeAlD
Vitamin E—GSTP1—telencephalon—schizophrenia	0.000716	0.00415	CbGeAlD
Vitamin E—GCLC—brain—schizophrenia	0.000709	0.00411	CbGeAlD
Vitamin E—GSTA2—endocrine gland—schizophrenia	0.000704	0.00408	CbGeAlD
Vitamin E—PRKCA—nervous system—schizophrenia	0.000687	0.00398	CbGeAlD
Vitamin E—SOD1—cerebellum—schizophrenia	0.000668	0.00387	CbGeAlD
Vitamin E—PRKCA—central nervous system—schizophrenia	0.000662	0.00384	CbGeAlD
Vitamin E—GSTA2—nervous system—schizophrenia	0.000658	0.00382	CbGeAlD
Vitamin E—PRKCA—cerebellum—schizophrenia	0.000647	0.00375	CbGeAlD
Vitamin E—GSTA2—central nervous system—schizophrenia	0.000634	0.00368	CbGeAlD
Vitamin E—GSTM3—brain—schizophrenia	0.000634	0.00367	CbGeAlD
Vitamin E—ALOX5—blood—schizophrenia	0.000633	0.00367	CbGeAlD
Vitamin E—GSTP1—gonad—schizophrenia	0.000598	0.00346	CbGeAlD
Vitamin E—GSTO1—brain—schizophrenia	0.00059	0.00342	CbGeAlD
Vitamin E—NQO1—midbrain—schizophrenia	0.000575	0.00334	CbGeAlD
Vitamin E—ALOX5—endocrine gland—schizophrenia	0.000549	0.00318	CbGeAlD
Vitamin E—SOD1—brain—schizophrenia	0.000542	0.00314	CbGeAlD
Vitamin E—PRKCA—brain—schizophrenia	0.000525	0.00305	CbGeAlD
Vitamin E—GSTP1—blood—schizophrenia	0.000521	0.00302	CbGeAlD
Vitamin E—GSTP1—midbrain—schizophrenia	0.000514	0.00298	CbGeAlD
Vitamin E—ALOX5—nervous system—schizophrenia	0.000514	0.00298	CbGeAlD
Vitamin E—NQO1—endocrine gland—schizophrenia	0.000505	0.00293	CbGeAlD
Vitamin E—GSTA2—brain—schizophrenia	0.000503	0.00292	CbGeAlD
Vitamin E—ALOX5—central nervous system—schizophrenia	0.000495	0.00287	CbGeAlD
Vitamin E—ALOX5—cerebellum—schizophrenia	0.000484	0.0028	CbGeAlD
Vitamin E—NQO1—nervous system—schizophrenia	0.000473	0.00274	CbGeAlD
Vitamin E—NQO1—central nervous system—schizophrenia	0.000455	0.00264	CbGeAlD
Vitamin E—GSTP1—endocrine gland—schizophrenia	0.000452	0.00262	CbGeAlD
Vitamin E—NQO1—cerebellum—schizophrenia	0.000445	0.00258	CbGeAlD
Vitamin E—GSTP1—nervous system—schizophrenia	0.000423	0.00245	CbGeAlD
Vitamin E—GSTP1—central nervous system—schizophrenia	0.000407	0.00236	CbGeAlD
Vitamin E—GSTP1—cerebellum—schizophrenia	0.000398	0.00231	CbGeAlD
Vitamin E—ALOX5—brain—schizophrenia	0.000393	0.00228	CbGeAlD
Vitamin E—NQO1—brain—schizophrenia	0.000362	0.0021	CbGeAlD
Vitamin E—GSTP1—brain—schizophrenia	0.000323	0.00187	CbGeAlD
Vitamin E—PRKCA—Signaling by FGFR—AKT1—schizophrenia	1.15e-05	3.85e-05	CbGpPWpGaD
Vitamin E—PRKCA—EGF/EGFR Signaling Pathway—AKT1—schizophrenia	1.15e-05	3.85e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—FOS—schizophrenia	1.15e-05	3.84e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—TLE1—schizophrenia	1.15e-05	3.84e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—NRG3—schizophrenia	1.15e-05	3.84e-05	CbGpPWpGaD
Vitamin E—GSTA2—Metabolism—APOE—schizophrenia	1.15e-05	3.84e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.15e-05	3.84e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by ERBB2—AKT1—schizophrenia	1.14e-05	3.84e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—HLA-E—schizophrenia	1.14e-05	3.83e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—SNAP25—schizophrenia	1.14e-05	3.82e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—APOA1—schizophrenia	1.14e-05	3.82e-05	CbGpPWpGaD
Vitamin E—PRKCA—DAP12 signaling—AKT1—schizophrenia	1.14e-05	3.82e-05	CbGpPWpGaD
Vitamin E—GSTM3—Metabolism—EP300—schizophrenia	1.14e-05	3.81e-05	CbGpPWpGaD
Vitamin E—DGKA—Signaling Pathways—EP300—schizophrenia	1.13e-05	3.8e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—GFAP—schizophrenia	1.13e-05	3.8e-05	CbGpPWpGaD
Vitamin E—GSTA2—Metabolism—APOA1—schizophrenia	1.13e-05	3.8e-05	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—PLA2G4A—schizophrenia	1.12e-05	3.76e-05	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—GSTM1—schizophrenia	1.12e-05	3.76e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—GRM5—schizophrenia	1.12e-05	3.75e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—ABCB1—schizophrenia	1.12e-05	3.75e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—ERBB4—schizophrenia	1.11e-05	3.73e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by Wnt—EP300—schizophrenia	1.11e-05	3.73e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—MTHFR—schizophrenia	1.11e-05	3.71e-05	CbGpPWpGaD
Vitamin E—PRKCA—Gene Expression—HSPA1A—schizophrenia	1.1e-05	3.69e-05	CbGpPWpGaD
Vitamin E—SOD1—Hemostasis—TP53—schizophrenia	1.09e-05	3.66e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—CACNA1C—schizophrenia	1.09e-05	3.66e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—S100B—schizophrenia	1.09e-05	3.66e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—PLA2G4A—schizophrenia	1.09e-05	3.66e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—PLA2G4A—schizophrenia	1.09e-05	3.64e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—GSTM1—schizophrenia	1.09e-05	3.64e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—TLE3—schizophrenia	1.09e-05	3.64e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—GSK3B—schizophrenia	1.08e-05	3.62e-05	CbGpPWpGaD
Vitamin E—PRKCB—Hemostasis—TP53—schizophrenia	1.08e-05	3.62e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—FOS—schizophrenia	1.07e-05	3.6e-05	CbGpPWpGaD
Vitamin E—PRKCA—DAP12 interactions—AKT1—schizophrenia	1.07e-05	3.59e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by FGFR in disease—AKT1—schizophrenia	1.07e-05	3.59e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—NRG1—schizophrenia	1.07e-05	3.59e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—GSK3B—schizophrenia	1.07e-05	3.57e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—PIK3C2A—schizophrenia	1.06e-05	3.57e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by EGFR—AKT1—schizophrenia	1.06e-05	3.56e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—MEF2C—schizophrenia	1.06e-05	3.56e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by EGFR in Cancer—AKT1—schizophrenia	1.05e-05	3.53e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by PDGF—AKT1—schizophrenia	1.05e-05	3.51e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—PLA2G4A—schizophrenia	1.05e-05	3.51e-05	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—GSK3B—schizophrenia	1.05e-05	3.51e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—ERBB4—schizophrenia	1.04e-05	3.5e-05	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—FOS—schizophrenia	1.04e-05	3.49e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—MTHFR—schizophrenia	1.04e-05	3.48e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Hemostasis—TP53—schizophrenia	1.04e-05	3.47e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—APOE—schizophrenia	1.03e-05	3.45e-05	CbGpPWpGaD
Vitamin E—GSTO1—Metabolism—EP300—schizophrenia	1.03e-05	3.45e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—NRG1—schizophrenia	1.03e-05	3.45e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—YWHAZ—schizophrenia	1.03e-05	3.44e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—CCK—schizophrenia	1.02e-05	3.43e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—HSPA1A—schizophrenia	1.02e-05	3.43e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—PRL—schizophrenia	1.02e-05	3.42e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—MEF2C—schizophrenia	1.02e-05	3.42e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—APOA1—schizophrenia	1.02e-05	3.41e-05	CbGpPWpGaD
Vitamin E—PRKCB—Cell Cycle—TP53—schizophrenia	1.02e-05	3.41e-05	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—MTHFR—schizophrenia	1.02e-05	3.41e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—NOS1—schizophrenia	1.02e-05	3.41e-05	CbGpPWpGaD
Vitamin E—PRKCA—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	1.01e-05	3.38e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—ERBB3—schizophrenia	1e-05	3.36e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—PDE4B—schizophrenia	9.99e-06	3.35e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—GSK3B—schizophrenia	9.99e-06	3.35e-05	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—MTHFR—schizophrenia	9.93e-06	3.33e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—YWHAZ—schizophrenia	9.85e-06	3.3e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—CCKAR—schizophrenia	9.83e-06	3.29e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—PLA2G4A—schizophrenia	9.81e-06	3.29e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Cell Cycle—TP53—schizophrenia	9.79e-06	3.28e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Hemostasis—TP53—schizophrenia	9.71e-06	3.25e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—APOE—schizophrenia	9.66e-06	3.24e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—HTR2A—schizophrenia	9.66e-06	3.23e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—ERBB3—schizophrenia	9.64e-06	3.23e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—NRG1—schizophrenia	9.63e-06	3.23e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—MTHFR—schizophrenia	9.61e-06	3.22e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—CYP2D6—schizophrenia	9.55e-06	3.2e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—SNAP25—schizophrenia	9.55e-06	3.2e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—MEF2C—schizophrenia	9.55e-06	3.2e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—APOA1—schizophrenia	9.55e-06	3.2e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—ADORA2A—schizophrenia	9.53e-06	3.19e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—S100B—schizophrenia	9.52e-06	3.19e-05	CbGpPWpGaD
Vitamin E—PRKCA—NGF signalling via TRKA from the plasma membrane—AKT1—schizophrenia	9.49e-06	3.18e-05	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—APOE—schizophrenia	9.48e-06	3.18e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—PRL—schizophrenia	9.43e-06	3.16e-05	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—APOA1—schizophrenia	9.37e-06	3.14e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by GPCR—PLA2G4A—schizophrenia	9.37e-06	3.14e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—HTR2A—schizophrenia	9.27e-06	3.11e-05	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—APOE—schizophrenia	9.24e-06	3.1e-05	CbGpPWpGaD
Vitamin E—SOD1—Hemostasis—AKT1—schizophrenia	9.23e-06	3.09e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—YWHAZ—schizophrenia	9.23e-06	3.09e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Cell Cycle—TP53—schizophrenia	9.17e-06	3.07e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—FGA—schizophrenia	9.14e-06	3.06e-05	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—APOA1—schizophrenia	9.13e-06	3.06e-05	CbGpPWpGaD
Vitamin E—PRKCA—GPCR downstream signaling—HTR2A—schizophrenia	9.13e-06	3.06e-05	CbGpPWpGaD
Vitamin E—PRKCB—Hemostasis—AKT1—schizophrenia	9.12e-06	3.05e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—ERBB4—schizophrenia	9.11e-06	3.05e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism of mRNA—AKT1—schizophrenia	9.04e-06	3.03e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—ERBB3—schizophrenia	9.02e-06	3.02e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—APOE—schizophrenia	8.98e-06	3.01e-05	CbGpPWpGaD
Vitamin E—PRKCA—Platelet activation, signaling and aggregation—AKT1—schizophrenia	8.97e-06	3.01e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—APOE—schizophrenia	8.95e-06	3e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—NPY—schizophrenia	8.9e-06	2.98e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—NOTCH4—schizophrenia	8.9e-06	2.98e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—ATP2A2—schizophrenia	8.9e-06	2.98e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—APOA1—schizophrenia	8.87e-06	2.97e-05	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—IL1B—schizophrenia	8.85e-06	2.97e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—APOA1—schizophrenia	8.85e-06	2.96e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Hemostasis—AKT1—schizophrenia	8.76e-06	2.93e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—HTR2A—schizophrenia	8.69e-06	2.91e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—CYP1A2—schizophrenia	8.64e-06	2.89e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—APOE—schizophrenia	8.62e-06	2.89e-05	CbGpPWpGaD
Vitamin E—GCLC—Metabolism—EP300—schizophrenia	8.62e-06	2.89e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—HTR1B—schizophrenia	8.59e-06	2.88e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—OXT—schizophrenia	8.59e-06	2.88e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—ESR1—schizophrenia	8.57e-06	2.87e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—APOA1—schizophrenia	8.52e-06	2.86e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—TH—schizophrenia	8.51e-06	2.85e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—IL1B—schizophrenia	8.5e-06	2.85e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—ERBB4—schizophrenia	8.41e-06	2.82e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—NRG1—schizophrenia	8.4e-06	2.82e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—MEF2C—schizophrenia	8.33e-06	2.79e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by GPCR—HTR2A—schizophrenia	8.29e-06	2.78e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—HTR1A—schizophrenia	8.27e-06	2.77e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—ESR1—schizophrenia	8.23e-06	2.76e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Hemostasis—AKT1—schizophrenia	8.2e-06	2.75e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—NPS—schizophrenia	8.14e-06	2.73e-05	CbGpPWpGaD
Vitamin E—DGKA—Signaling Pathways—TP53—schizophrenia	8.12e-06	2.72e-05	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle, Mitotic—EP300—schizophrenia	8.08e-06	2.71e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—APOE—schizophrenia	8.07e-06	2.71e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—YWHAZ—schizophrenia	8.05e-06	2.7e-05	CbGpPWpGaD
Vitamin E—PRKCA—Gene Expression—YWHAZ—schizophrenia	8e-06	2.68e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—HTR2C—schizophrenia	7.99e-06	2.68e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—DRD1—schizophrenia	7.99e-06	2.68e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—APOA1—schizophrenia	7.98e-06	2.67e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—IL1B—schizophrenia	7.96e-06	2.67e-05	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—EP300—schizophrenia	7.91e-06	2.65e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Innate Immune System—AKT1—schizophrenia	7.88e-06	2.64e-05	CbGpPWpGaD
Vitamin E—PRKCB—Adaptive Immune System—AKT1—schizophrenia	7.88e-06	2.64e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—ERBB3—schizophrenia	7.87e-06	2.64e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—GSK3B—schizophrenia	7.77e-06	2.6e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—NTRK2—schizophrenia	7.77e-06	2.6e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—NRG1—schizophrenia	7.76e-06	2.6e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism of RNA—AKT1—schizophrenia	7.74e-06	2.59e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—DRD3—schizophrenia	7.73e-06	2.59e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—ESR1—schizophrenia	7.71e-06	2.58e-05	CbGpPWpGaD
Vitamin E—PRKCA—Hemostasis—EP300—schizophrenia	7.65e-06	2.56e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—EP300—schizophrenia	7.6e-06	2.55e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Adaptive Immune System—AKT1—schizophrenia	7.57e-06	2.54e-05	CbGpPWpGaD
Vitamin E—HMOX1—Metabolism—AKT1—schizophrenia	7.57e-06	2.54e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—DRD4—schizophrenia	7.51e-06	2.52e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—GSK3B—schizophrenia	7.47e-06	2.5e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—YWHAZ—schizophrenia	7.43e-06	2.49e-05	CbGpPWpGaD
Vitamin E—GSTO1—Disease—AKT1—schizophrenia	7.42e-06	2.49e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—AKT1—schizophrenia	7.38e-06	2.47e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by NGF—AKT1—schizophrenia	7.3e-06	2.45e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—ERBB3—schizophrenia	7.27e-06	2.44e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—COMT—schizophrenia	7.24e-06	2.42e-05	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle—EP300—schizophrenia	7.22e-06	2.42e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—GSTP1—schizophrenia	7.2e-06	2.41e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—MAOA—schizophrenia	7.19e-06	2.41e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—CNR1—schizophrenia	7.17e-06	2.4e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—EP300—schizophrenia	7.12e-06	2.38e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Adaptive Immune System—AKT1—schizophrenia	7.09e-06	2.38e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—EP300—schizophrenia	7.02e-06	2.35e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—HTR7—schizophrenia	6.99e-06	2.34e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—DRD2—schizophrenia	6.99e-06	2.34e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—GSK3B—schizophrenia	6.99e-06	2.34e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—MTHFR—schizophrenia	6.99e-06	2.34e-05	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—EP300—schizophrenia	6.89e-06	2.31e-05	CbGpPWpGaD
Vitamin E—GSTM3—Metabolism—AKT1—schizophrenia	6.87e-06	2.3e-05	CbGpPWpGaD
Vitamin E—DGKA—Signaling Pathways—AKT1—schizophrenia	6.86e-06	2.3e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—ABCB1—schizophrenia	6.82e-06	2.28e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by Wnt—AKT1—schizophrenia	6.72e-06	2.25e-05	CbGpPWpGaD
Vitamin E—PRKCA—Gene Expression—ESR1—schizophrenia	6.69e-06	2.24e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—GSTM1—schizophrenia	6.62e-06	2.22e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—PLA2G4A—schizophrenia	6.62e-06	2.22e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—PRL—schizophrenia	6.6e-06	2.21e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—EP300—schizophrenia	6.57e-06	2.2e-05	CbGpPWpGaD
Vitamin E—GSTA2—Metabolism—EP300—schizophrenia	6.53e-06	2.19e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—APOE—schizophrenia	6.5e-06	2.18e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—APOA1—schizophrenia	6.43e-06	2.15e-05	CbGpPWpGaD
Vitamin E—GSTO1—Metabolism—AKT1—schizophrenia	6.22e-06	2.08e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—S100B—schizophrenia	6.16e-06	2.06e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—GSK3B—schizophrenia	6.1e-06	2.04e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—FOS—schizophrenia	6.06e-06	2.03e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—ERBB4—schizophrenia	5.89e-06	1.97e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—EP300—schizophrenia	5.88e-06	1.97e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—MTHFR—schizophrenia	5.85e-06	1.96e-05	CbGpPWpGaD
Vitamin E—PRKCB—GPCR downstream signaling—AKT1—schizophrenia	5.76e-06	1.93e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—GSK3B—schizophrenia	5.63e-06	1.89e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—PLA2G4A—schizophrenia	5.53e-06	1.85e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—EP300—schizophrenia	5.5e-06	1.84e-05	CbGpPWpGaD
Vitamin E—PRKCA—Hemostasis—TP53—schizophrenia	5.48e-06	1.84e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—APOE—schizophrenia	5.45e-06	1.82e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—NRG1—schizophrenia	5.43e-06	1.82e-05	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—EP300—schizophrenia	5.4e-06	1.81e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—MEF2C—schizophrenia	5.38e-06	1.8e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—APOA1—schizophrenia	5.38e-06	1.8e-05	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—EP300—schizophrenia	5.27e-06	1.76e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling by GPCR—AKT1—schizophrenia	5.23e-06	1.75e-05	CbGpPWpGaD
Vitamin E—GCLC—Metabolism—AKT1—schizophrenia	5.21e-06	1.75e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—YWHAZ—schizophrenia	5.2e-06	1.74e-05	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle—TP53—schizophrenia	5.17e-06	1.73e-05	CbGpPWpGaD
Vitamin E—NR1I2—Gene Expression—AKT1—schizophrenia	5.15e-06	1.73e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—EP300—schizophrenia	5.12e-06	1.71e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—EP300—schizophrenia	5.1e-06	1.71e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—ERBB3—schizophrenia	5.09e-06	1.71e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling by GPCR—AKT1—schizophrenia	5.03e-06	1.68e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—EP300—schizophrenia	4.91e-06	1.65e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—HTR2A—schizophrenia	4.9e-06	1.64e-05	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—AKT1—schizophrenia	4.78e-06	1.6e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling by GPCR—AKT1—schizophrenia	4.71e-06	1.58e-05	CbGpPWpGaD
Vitamin E—PRKCA—Hemostasis—AKT1—schizophrenia	4.63e-06	1.55e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—EP300—schizophrenia	4.6e-06	1.54e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—AKT1—schizophrenia	4.59e-06	1.54e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—APOE—schizophrenia	4.55e-06	1.53e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—APOA1—schizophrenia	4.5e-06	1.51e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—IL1B—schizophrenia	4.49e-06	1.5e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—ESR1—schizophrenia	4.35e-06	1.46e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—AKT1—schizophrenia	4.3e-06	1.44e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Gene Expression—AKT1—schizophrenia	4.28e-06	1.43e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—AKT1—schizophrenia	4.24e-06	1.42e-05	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—AKT1—schizophrenia	4.16e-06	1.4e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—EP300—schizophrenia	4.01e-06	1.34e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—AKT1—schizophrenia	3.97e-06	1.33e-05	CbGpPWpGaD
Vitamin E—GSTA2—Metabolism—AKT1—schizophrenia	3.95e-06	1.32e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—GSK3B—schizophrenia	3.94e-06	1.32e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—EP300—schizophrenia	3.71e-06	1.24e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—TP53—schizophrenia	3.66e-06	1.23e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—AKT1—schizophrenia	3.55e-06	1.19e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—TP53—schizophrenia	3.52e-06	1.18e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—AKT1—schizophrenia	3.33e-06	1.11e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—TP53—schizophrenia	3.29e-06	1.1e-05	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—AKT1—schizophrenia	3.27e-06	1.09e-05	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—AKT1—schizophrenia	3.18e-06	1.07e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—EP300—schizophrenia	3.1e-06	1.04e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—AKT1—schizophrenia	3.09e-06	1.04e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—AKT1—schizophrenia	3.08e-06	1.03e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—AKT1—schizophrenia	2.97e-06	9.95e-06	CbGpPWpGaD
Vitamin E—PRKCA—GPCR downstream signaling—AKT1—schizophrenia	2.92e-06	9.8e-06	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—AKT1—schizophrenia	2.78e-06	9.32e-06	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by GPCR—AKT1—schizophrenia	2.65e-06	8.89e-06	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—EP300—schizophrenia	2.6e-06	8.7e-06	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—AKT1—schizophrenia	2.43e-06	8.13e-06	CbGpPWpGaD
Vitamin E—PRKCA—Gene Expression—AKT1—schizophrenia	2.41e-06	8.08e-06	CbGpPWpGaD
Vitamin E—PRKCA—Disease—AKT1—schizophrenia	2.24e-06	7.5e-06	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—AKT1—schizophrenia	1.88e-06	6.28e-06	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—TP53—schizophrenia	1.86e-06	6.22e-06	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—AKT1—schizophrenia	1.57e-06	5.25e-06	CbGpPWpGaD
